EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrin-Linked Kinase (ILK) Promotes Mitochondrial Dysfunction by Decreasing CPT1A Expression in a Folic Acid-Based Model of Kidney Disease

Mariano de la Serna-Soto, Laura Calleros iD, María Martos-Elvira, Ariadna Moreno-Piedra, Sergio García-Villoria, Mercedes Griera, Elena Alcalde-Estévez iD, Ana Asenjo-Bueno, Diego Rodríguez-Puyol, Sergio de Frutos iD, María Piedad Ruiz-Torres

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26051861 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mariano de la Serna-Soto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Biology, Universidad de Alcalá, Instituto Ramon y Cajal de Investigación Sanitaria, RICORS 2040, Fundación Renal Iñigo Álvarez …. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Mitochondria, Folic Acid, Carnitine O-Palmitoyltransferase. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Comunidad de Madrid, Instituto de Salud Carlos III, Universidad de Alcalá.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Integrin-linked kinase (ILK) is a key scaffolding protein between extracellular matrix protein and the cytoskeleton and has been implicated previously in the pathogenesis of renal damage. However, its involvement in renal mitochondrial dysfunction remains to be elucidated. We studied the role of ILK and its downstream regulations in renal damage and mitochondria function both in vivo and vitro, using a folic acid (FA)-induced kidney disease model. Wild type (WT) and ILK conditional-knockdown (cKD-ILK) mice were injected with a single intraperitoneal dose of FA and studied after 15 days of chronic renal damage progression. Human Kidney tubular epithelial cells (HK2) were transfected with specific siRNAs targeting ILK, glycogen synthase kinase 3-β (GSK3β), or CCAAT/enhancer binding protein-β (C/EBPβ). The expressions and activities of renal ILK, GSK3β, C/EBPβ, mitochondrial oxidative phosphorylation enzymes, and mitochondrial membrane potential were assessed. Additionally, the expression of markers for fibrosis fibronectin (FN) and collagen 1 (COL1A1), for autophagy p62 and cytosolic light chain 3 (LC3B) isoforms II and I, and mitochondrial homeostasis marker carnitine palmitoyl-transferase 1A (CPT1A) were evaluated using immunoblotting, RT-qPCR, immunofluorescence, or colorimetric assays. FA upregulated ILK expression, leading to the decrease of GSK3β activity, increased tubular fibrosis, and produced mitochondrial dysfunction, both in vivo and vitro. These alterations were fully or partially reversed upon ILK depletion, mitigating FA-induced renal damage. The signaling axis composed by ILK, GSK3β, and C/EBPβ regulated CPT1A transcription as the limiting factor in the FA-based impaired mitochondrial activity. We highlight ILK as a potential therapeutical target for preserving mitochondrial function in kidney injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesMitochondriaFolic AcidCarnitine O-PalmitoyltransferaseKidney DiseasesAnimalsMiceHumansDisease Models, AnimalGlycogen Synthase Kinase 3 betaMaleCell LineCCAAT-Enhancer-Binding Protein-betaMice, Inbred C57BLScaffold Protein ILK

Stichwörter der Autor:innen

AKI-to-CKD transitionC/EBP?CPT1AGSK3?HK2ILKautophagyfibrosisfolic acidkidney diseasemitochondriaoxidative phosphorylation

Substanzen

Protein Serine-Threonine KinasesFolic AcidGlycogen Synthase Kinase 3 betaCarnitine O-PalmitoyltransferaseCCAAT-Enhancer-Binding Protein-betaScaffold Protein ILK

Autor:innen und Institutionen

  • Department of Systems Biology, Universidad de Alcalá, Instituto Ramon y Cajal de Investigación Sanitaria, RICORS 2040, Fundación Renal Iñigo Álvarez de Toledo, INNOREN-CM, Alcalá de Henares, 28871 Madrid, Spain.
  • Graphenano Medical Care S.L., Alcalá de Henares, 28871 Madrid, Spain.
  • Department of Medicine, Universidad de Alcalá, Nephrology Service at Hospital Príncipe de Asturias, Instituto Ramon y Cajal de Investigación Sanitaria, RICORS 2040, Fundación Renal Iñigo Álvarez de Toledo, INNOREN-CM, A…

ORCID-Profile: Laura Calleros, Elena Alcalde-Estévez, Sergio de Frutos

Förderung

  • Comunidad de Madrid
  • Instituto de Salud Carlos III
  • Universidad de Alcalá
  • NIMHD NIH HHS
  • RETIC REDinREN
  • RICORS 2040 programs
  • INNOREN-CM

Zitieren

APA

de la Serna-Soto, M., Calleros, L., Martos-Elvira, M., Moreno-Piedra, A., García-Villoria, S., Griera, M., Alcalde-Estévez, E., Asenjo-Bueno, A., Rodríguez-Puyol, D., de Frutos, S., & Ruiz-Torres, M. P. (2025). Integrin-Linked Kinase (ILK) Promotes Mitochondrial Dysfunction by Decreasing CPT1A Expression in a Folic Acid-Based Model of Kidney Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26051861

Vancouver

de la Serna-Soto M, Calleros L, Martos-Elvira M, Moreno-Piedra A, García-Villoria S, Griera M, et al. Integrin-Linked Kinase (ILK) Promotes Mitochondrial Dysfunction by Decreasing CPT1A Expression in a Folic Acid-Based Model of Kidney Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26051861

BibTeX
@article{delaSernaSoto2025,
  author = {de la Serna-Soto, Mariano and Calleros, Laura and Martos-Elvira, María and Moreno-Piedra, Ariadna and García-Villoria, Sergio and Griera, Mercedes and Alcalde-Estévez, Elena and Asenjo-Bueno, Ana and Rodríguez-Puyol, Diego and de Frutos, Sergio and Ruiz-Torres, María Piedad},
  title = {Integrin-Linked Kinase (ILK) Promotes Mitochondrial Dysfunction by Decreasing CPT1A Expression in a Folic Acid-Based Model of Kidney Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26051861}
}
Kostenlos starten →